Journal of Viral Hepatitis

Cover image for Vol. 18 Issue 4

April 2011

Volume 18, Issue 4

Pages 229–304, e1–e166

  1. REVIEW ARTICLE

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    4. SHORT REPORT
    5. ORIGINAL ARTICLES
    6. Original Articles
    7. ORIGINAL ARTICLES
  2. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    4. SHORT REPORT
    5. ORIGINAL ARTICLES
    6. Original Articles
    7. ORIGINAL ARTICLES
    1. Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway (pages 237–244)

      M. G. Kristiansen, M. -L. Løchen, T. J. Gutteberg, L. Mortensen, B. O. Eriksen and J. Florholmen

      Version of Record online: 8 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01290.x

      • image
      • image
    2. Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection (pages 245–251)

      C. Pedersen, Å. Alsiö, M. Lagging, N. Langeland, M. Färkkilä, M. Rauning Buhl, K. Mørch, J. Westin, P. Sangfelt, G. Norkrans, P. Brehm Christensen and for the NORDynamicIC Study Group

      Version of Record online: 1 APR 2010 | DOI: 10.1111/j.1365-2893.2010.01303.x

      • image
      • image
    3. Quality of life in patients with various liver diseases : Patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment (pages 252–261)

      H. L. Tillmann, M. Wiese, Y. Braun, J. Wiegand, S. Tenckhoff, J. Mössner, M. P. Manns and K. Weissenborn

      Version of Record online: 8 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01292.x

      • image
      • image
      • image
      • image
    4. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots (pages 262–270)

      V. D. Hope, M. Hickman, S. L. Ngui, S. Jones, M. Telfer, M. Bizzarri, F. Ncube and J. V. Parry

      Version of Record online: 27 APR 2010 | DOI: 10.1111/j.1365-2893.2010.01297.x

    5. Controlled release recombinant human interferon-α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial (pages 271–279)

      I. Dzyublyk, T. Yegorova, L. Moroz, O. Popovych, I. Zaytsev, V. Miroshnichenko, A. Kromminga, M. M. Wilkes, E. J. van Hoogdalem and J. E. Humphries

      Version of Record online: 28 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01298.x

      • image
      • image
      • image
      • image
    6. Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy (pages 280–286)

      K. Hayashi, Y. Katano, M. Ishigami, A. Itoh, Y. Hirooka, I. Nakano, F. Urano, K. Yoshioka, H. Toyoda, T. Kumada and H. Goto

      Version of Record online: 28 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01305.x

      • image
    7. Virologic and biochemical responses to clevudine in patients with chronic HBV infection- associated cirrhosis: data at week 48 (pages 287–293)

      J. H. Kim, H. J. Yim, E. S. Jung, Y. K. Jung, J. H. Kim, Y. S. Seo, J. E. Yeon, H. S. Lee, S. H. Um and K. S. Byun

      Version of Record online: 28 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01304.x

      • image
    8. Clinical, epidemiological characteristics and indications for liver biopsy and treatment in immigrants with chronic hepatitis B at a referral hospital in Madrid (pages 294–299)

      J. A. Pérez-Molina, J. M. Herrero-Martínez, F. Norman, A. Pérez-Ayala, B. Monge-Mahillo, M. Navarro-Beltrá and R. López-Vélez

      Version of Record online: 28 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01306.x

      • image
  3. SHORT REPORT

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    4. SHORT REPORT
    5. ORIGINAL ARTICLES
    6. Original Articles
    7. ORIGINAL ARTICLES
    1. Single-step real-time PCR to quantify hepatitis B virus and distinguish genotype D from non-D genotypes (pages 300–304)

      S. Amini-Bavil-Olyaee, M. R. Pourkarim, S. Schaefer, F. Mahboudi, M. Van Ranst, A. Adeli, C. Trautwein and F. Tacke

      Version of Record online: 29 MAR 2010 | DOI: 10.1111/j.1365-2893.2010.01308.x

      • image
  4. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    4. SHORT REPORT
    5. ORIGINAL ARTICLES
    6. Original Articles
    7. ORIGINAL ARTICLES
    1. Hepatitis A outbreaks: the effect of a mass vaccination programme (pages e1–e4)

      N. Torner, S. Broner, A. Martinez, P. Godoy, J. Batalla, A. Dominguez and the Hepatitis A Surveillance Group of Catalonia

      Version of Record online: 3 DEC 2010 | DOI: 10.1111/j.1365-2893.2010.01395.x

      • image
      • image
    2. Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers (pages e5–e10)

      A. De Schryver, K. Verstrepen, L. Vandersmissen, N. Vandermeeren, I. Vernaillen, R. Vranckx, P. Van Damme and M. van Sprundel

      Version of Record online: 24 AUG 2010 | DOI: 10.1111/j.1365-2893.2010.01365.x

    3. An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes (pages e20–e28)

      V. A. Arankalle, S. Gandhi, K. S. Lole, M. S. Chadha, G. M. Gupte and M. U. Lokhande

      Version of Record online: 26 NOV 2010 | DOI: 10.1111/j.1365-2893.2010.01391.x

      • image
      • image
    4. Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection (pages e29–e39)

      Y. Liu, C. Wang, Y. Zhong, X. Li, J. Dai, X. Ren, Z. Xu, L. Li, Z. Yao, D. Ji, L. Wang, L. Zhang, V. W. -S. Wong, F. Zoulim and D. Xu

      Version of Record online: 6 SEP 2010 | DOI: 10.1111/j.1365-2893.2010.01360.x

      • image
      • image
    5. You have full text access to this OnlineOpen article
    6. Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients (pages e52–e60)

      E. S. A. Araújo, H. Dahari, A. U. Neumann, N. de Paula Cavalheiro, C. E. Melo, E. S. de Melo, T. J. Layden, S. J. Cotler and A. A. Barone

      Version of Record online: 3 AUG 2010 | DOI: 10.1111/j.1365-2893.2010.01358.x

      • image
      • image
    7. Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993–2007 (pages e61–e65)

      S. A. McDonald, S. J. Hutchinson, S. Cameron, S. M. Bird, P. R. Mills, A. McLeod and D. J. Goldberg

      Version of Record online: 3 OCT 2010 | DOI: 10.1111/j.1365-2893.2010.01377.x

    8. Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort (pages e66–e74)

      L. N. Clausen, N. Weis, K. Astvad, K. Schønning, M. Fenger, H. Krarup, J. Bukh and T. Benfield

      Version of Record online: 12 NOV 2010 | DOI: 10.1111/j.1365-2893.2010.01392.x

      • image
    9. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific (pages e75–e80)

      S. Pritchett, A. Cardenas, D. Manning, M. Curry and N. H. Afdhal

      Version of Record online: 7 OCT 2010 | DOI: 10.1111/j.1365-2893.2010.01375.x

      • image
      • image
      • image
      • image
      • image
    10. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy (pages e81–e90)

      S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

      Version of Record online: 16 SEP 2010 | DOI: 10.1111/j.1365-2893.2010.01372.x

      • image
    11. The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C (pages e91–e98)

      A. G. Vigani, A. Macedo de Oliveira, R. Tozzo, M. H. P. Pavan, E. S. Gonçales, V. Fais, N. S. Gonçales and F. L. Gonçales

      Version of Record online: 25 OCT 2010 | DOI: 10.1111/j.1365-2893.2010.01385.x

    12. Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia (pages e104–e116)

      J. Grebely, J. Bryant, P. Hull, M. Hopwood, Y. Lavis, G. J. Dore and C. Treloar

      Version of Record online: 14 SEP 2010 | DOI: 10.1111/j.1365-2893.2010.01370.x

      • image
  5. Original Articles

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    4. SHORT REPORT
    5. ORIGINAL ARTICLES
    6. Original Articles
    7. ORIGINAL ARTICLES
  6. ORIGINAL ARTICLES

    1. Top of page
    2. REVIEW ARTICLE
    3. ORIGINAL ARTICLES
    4. SHORT REPORT
    5. ORIGINAL ARTICLES
    6. Original Articles
    7. ORIGINAL ARTICLES
    1. The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population (pages e126–e133)

      S. A. McDonald, S. J. Hutchinson, P. R. Mills, S. M. Bird, S. Cameron, J. F. Dillon and D. J. Goldberg

      Version of Record online: 22 OCT 2010 | DOI: 10.1111/j.1365-2893.2010.01380.x

      • image
    2. Hepatitis C treatment among racial and ethnic groups in the IDEAL trial (pages e134–e143)

      A. J. Muir, K. -Q. Hu, S. C. Gordon, K. Koury, N. Boparai, S. Noviello, J. K. Albrecht, M. S. Sulkowski and J. McCone

      Version of Record online: 25 NOV 2010 | DOI: 10.1111/j.1365-2893.2010.01402.x

      • image
      • image
    3. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort (pages e144–e152)

      D. Ramcharran, A. S. Wahed, H. S. Conjeevaram, R. W. Evans, T. Wang, S. H. Belle and L. J. Yee

      Version of Record online: 10 NOV 2010 | DOI: 10.1111/j.1365-2893.2010.01394.x

      • image
      • image
      • image
    4. GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection (pages e153–e159)

      B. Boodram, R. C. Hershow, D. Klinzman and J. T. Stapleton

      Version of Record online: 3 AUG 2010 | DOI: 10.1111/j.1365-2893.2010.01350.x

      • image
    5. Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis (pages e160–e166)

      M. F. C. Beersma, G. M. G. M. Verjans, H. J. Metselaar, A. D. M. E. Osterhaus, W. R. Berrington and G. J. van Doornum

      Version of Record online: 12 AUG 2010 | DOI: 10.1111/j.1365-2893.2010.01352.x

      • image
      • image

SEARCH

SEARCH BY CITATION